Is EPGNY or QYLD a better dividend investment in 2026?

EPGNY currently yields 113.84% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: EPGNY offers higher current income.

What is the dividend yield difference between EPGNY and QYLD?

EPGNY has a forward dividend yield of 113.84% ($2.72/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 101.92 percentage points.

Home › Compare › EPGNY vs QYLD

EPGNY vs QYLD: Dividend Comparison 2026

EPGNY yields 113.84% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EPGNY wins by $6.73M in total portfolio value

INVESTMENT

TIME HORIZON10 years

EPGNY

● Live price

113.84%

Share price

$2.39

Annual div

$2.72

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$6.75M

Annual income

$2,475,584.99

Full EPGNY calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — EPGNY vs QYLD

📍 EPGNY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EPGNY	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EPGNY + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EPGNY pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EPGNY

Annual income on $10K today (after 15% tax)

$9,676.26/yr

After 10yr DRIP, annual income (after tax)

$2,104,247.24/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, EPGNY beats the other by $2,099,436.83/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EPGNY + QYLD for your $10,000?

EPGNY: 50%QYLD: 50%

100% QYLD50/50100% EPGNY

Portfolio after 10yr

$3.39M

Annual income

$1,240,622.16/yr

Blended yield

36.60%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EPGNY buys

QYLD buys

No recent congressional trades found for EPGNY or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEPGNYQYLD

Forward yield	113.84% ✓	11.92%
Annual dividend / share	$2.72 ✓	$2.04
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$6.75M	$25.4K ✓
Annual income after 10y	$2,475,584.99 ✓	$5,659.31
Total dividends collected	$6.11M	$27.1K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: EPGNY vs QYLD ($10,000, DRIP)

Year	EPGNY Portfolio	EPGNY Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$22,084	$11,383.83	$10,352	$1,192.36	+$11.7K → EPGNY
2	$47,125	$23,495.20	$10,830	$1,347.57	+$36.3K → EPGNY
3	$97,280	$46,856.67	$11,460	$1,539.07	+$85.8K → EPGNY
4	$194,489	$90,398.69	$12,275	$1,777.84	+$182.2K → EPGNY
5	$377,010	$168,906.98	$13,323	$2,078.95	+$363.7K → EPGNY
6	$709,401	$306,000.59	$14,667	$2,463.34	+$694.7K → EPGNY
7	$1,297,177	$538,118.21	$16,396	$2,960.57	+$1.28M → EPGNY
8	$2,307,585	$919,605.21	$18,631	$3,612.97	+$2.29M → EPGNY
9	$3,998,005	$1,528,889.11	$21,548	$4,482.15	+$3.98M → EPGNY
10	$6,753,450	$2,475,584.99	$25,398	$5,659.31	+$6.73M → EPGNY

EPGNY vs QYLD: Complete Analysis 2026

EPGNY — Stock

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.

Full EPGNY Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this EPGNY vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EPGNY vs SCHD EPGNY vs JEPI EPGNY vs O EPGNY vs KO EPGNY vs MAIN EPGNY vs XYLD EPGNY vs JEPQ EPGNY vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.